Nonspecific urethritis - Symptoms, Causes, Treatment & Prevention

```html

Overview

Nonspecific urethritis (NSU) is an inflammation of the urethra that is not caused by the usual bacterial pathogens such as Neisseria gonorrhoeae or Chlamydia trachomatis. Instead, it is attributed to a broad group of organisms (including Mycoplasma, Ureaplasma, herpes simplex virus, and Trichomonas) or to non‑infectious irritants (chemical exposure, traumatic catheterization, allergic reactions). The term “nonspecific” reflects that the exact pathogen often cannot be identified using routine clinical tests.

NSU can affect anyone with a urethra, but it is most commonly diagnosed in sexually active adolescents and young adults. In the United States, urethritis accounts for roughly 10–15 % of all male urogenital complaints presenting to primary‑care or urgent‑care settings, and up to 30 % of those cases are classified as nonspecific after standard gonorrhea/chlamydia testing is negative.<sup>1</sup> Women are less frequently studied, but epidemiologic data suggest a prevalence of about 5 % in sexually active women with urethral symptoms.<sup>2</sup>

Symptoms

Symptoms of NSU can be subtle or prominent and often overlap with other urogenital infections. The most common manifestations include:

• Dysuria: Burning or painful urination, especially at the start of the stream.
• Urinary frequency or urgency: A sudden need to void, sometimes with small volumes.
• Urethral discharge: May be scant, clear, mucoid, or slightly purulent; less profuse than gonococcal discharge.
• Urethral itching or irritation: A sensation of “rawness” or tickle at the meatus.
• Painful ejaculation (in men): Discomfort during or after orgasm.
• Hematuria: Microscopic or occasional visible blood in urine.
• Perineal or suprapubic discomfort: Dull ache in the area between the scrotum and anus (men) or above the pubic bone (women).
• Lower abdominal pain: Occasionally present, especially if the infection spreads to the bladder (cystitis).

In many patients, especially women, symptoms can be mild enough to be mistaken for bladder irritation or a urinary “burn.” Always consider NSU when dysuria persists despite a negative Chlamydia/Gonorrhea screen.

Causes and Risk Factors

Infectious Causes

When a specific pathogen cannot be identified, clinicians label the condition “nonspecific.” The most common organisms implicated include:

• Mycoplasma genitalium – increasingly recognized as a cause of persistent urethritis; PCR detection rates range from 10–30 % in men with NSU.<sup>3</sup>
• Ureaplasma urealyticum – colonizes the genital tract; may trigger inflammation.
• Herpes simplex virus (HSV‑1/2) – can cause ulcerative or non‑ulcerative urethritis.
• Trichomonas vaginalis – especially in women; may present as urethral irritation.
• Non‑bacterial agents – adenovirus, adenomyosis, or even fungal organisms in immunocompromised hosts.

Non‑infectious Causes

• Chemical irritants: Exposure to soaps, spermicides, latex condoms, or douches.
• Physical trauma: Catheterization, urethral instrumentation, or vigorous sexual activity.
• Allergic reactions: To latex or lubricants.
• Autoimmune conditions: Rarely, diseases such as Behçet’s can involve the urethra.

Risk Factors

• New or multiple sexual partners (increased exposure to atypical pathogens).
• Inconsistent condom use.
• Recent urethral instrumentation (catheters, cystoscopy).
• Use of spermicidal products or irritating personal hygiene products.
• Immunocompromised states (HIV, diabetes, steroid therapy).
• History of previous urethritis or sexually transmitted infections.

Diagnosis

Accurate diagnosis relies on a systematic approach to rule out common STIs, identify possible atypical pathogens, and assess for non‑infectious etiologies.

Clinical Evaluation

1. History: Sexual history, recent instrumentation, product exposures, symptom timeline.
2. Physical exam: Visual inspection of the meatus, palpation for tenderness, assessment for genital lesions.

Laboratory Tests

• First‑line nucleic acid amplification tests (NAATs): Detect C. trachomatis and N. gonorrhoeae. A negative result prompts evaluation for NSU.
• Expanded NAAT panels: Some labs offer Mycoplasma genitalium, Ureaplasma urealyticum, and Trichomonas testing.
• Urine microscopy & culture: Looks for pyuria (≥10 WBC/hpf) without bacteria – a hallmark of NSU.
• Urethral swab: For patients with discharge, a swab for Gram stain, culture, and PCR.
• Serology: HSV IgM/IgG if herpetic infection is suspected.

Imaging (Rarely Needed)

If symptoms persist despite treatment, a renal‑bladder ultrasound or CT may be ordered to rule out upper‑tract involvement.

Diagnostic Criteria (CDC)

According to the CDC, NSU is diagnosed when a patient has:

• Symptoms of urethritis (dysuria, discharge, or urinary urgency) AND
• Evidence of inflammation (pyuria) on urinalysis, and
• Negative NAATs for C. trachomatis and N. gonorrhoeae.

Treatment Options

Treatment is empiric, targeting the most likely organisms while awaiting specialized test results. The CDC recommends a dual‑therapy approach.

First‑Line Antibiotic Regimens

Agent	Dosage	Duration
Doxycycline 100 mg PO BID	7 days	Standard for M. genitalium (if macrolide‑sensitive)
Azithromycin 1 g PO single dose	Single dose	Alternative for macrolide‑sensitive strains
Metronidazole 500 mg PO BID	7 days	Covers possible Trichomonas or anaerobes

Alternative/Second‑Line Options

• Fluoroquinolones (e.g., levofloxacin 500 mg daily for 5 days): Consider for macrolide‑resistant M. genitalium. Use cautiously due to resistance trends.
• Antiviral therapy (acyclovir 400 mg PO TID for 7 days): If HSV urethritis is confirmed.

Adjunctive Measures

• Analgesics: Ibuprofen 400 mg PO q6‑8h for pain.
• Hydration: Encourage 2–3 L of water daily to flush the urinary tract.
• Avoid irritants: Stop use of spermicides, perfumed soaps, or new lubricants during treatment.

When to Escalate to Procedures

If symptoms persist >2 weeks after appropriate antibiotics, consider:

• Cystoscopy to evaluate for urethral strictures or bladder pathology.
• Urethral dilation if a stricture has formed.

Living with Nonspecific Urethritis

Even after successful treatment, many patients experience anxiety about recurrence. Here are practical daily‑management tips:

• Maintain good genital hygiene: Gentle washing with warm water; avoid harsh soaps.
• Stay well‑hydrated: Dilutes urine and reduces irritation.
• Urinate after sexual activity: Helps clear any introduced organisms.
• Use water‑based, latex‑free lubricants: Reduce mechanical irritation.
• Monitor symptoms: Keep a brief diary of dysuria episodes, frequency, and any discharge.
• Follow‑up testing: Repeat NAATs 3–4 weeks after treatment if symptoms linger.
• Partner notification and treatment: Even if tests were negative, treating sex partners can prevent reinfection.

Prevention

Because many triggers are modifiable, preventive measures are effective:

• Consistent condom use: Reduces exposure to atypical pathogens.
• Limit new sexual partners: Fewer exposures, lower risk.
• Avoid irritating products: Choose fragrance‑free soaps, avoid douching, and select hypoallergenic condoms.
• Proper catheter care: Use sterile technique, limit catheter duration, and change catheters per protocol.
• Vaccination: HPV vaccine may reduce overall genital tract inflammation, though not directly linked to NSU.
• Regular screening: Annual STI screening for sexually active individuals helps catch infections early before they become “nonspecific.”

Complications

If NSU remains untreated or is repeatedly reinfected, the following complications can arise:

• Urethral stricture: Scarring narrows the urethral lumen, causing obstructive voiding.
• Chronic pelvic pain: Persistent inflammation can lead to pain syndromes.
• Epididymitis (men) or pelvic inflammatory disease (women): Ascending infection may affect adjacent structures.
• Infertility: In men, chronic prostatitis secondary to untreated urethritis can impair sperm quality.
• Increased susceptibility to future STIs: A damaged mucosal barrier is more easily colonized.

When to Seek Emergency Care

References

1. Mayo Clinic. “Urethritis.” Updated 2023. https://www.mayoclinic.org.
2. Cleveland Clinic. “Urethritis in Women.” 2022. https://my.clevelandclinic.org.
3. CDC. “Mycoplasma genitalium – CDC Fact Sheet.” 2024. https://www.cdc.gov.
4. World Health Organization. “Sexually transmitted infections (STIs) Fact Sheet.” 2023. https://www.who.int.
5. NIH National Institute of Allergy and Infectious Diseases. “Urethritis and Emerging Pathogens.” 2022. https://www.niaid.nih.gov.

```